-The Times of India The Cabinet on Thursday will consider a Bill providing for time-bound delivery of services like pensions, passports, caste certificates, ration cards and tax refunds with a penalty of Rs 250 a day subject to a maximum of Rs 50,000 for default. The right of citizens for time-bound delivery of goods and services and redressal of grievances Bill is to be enacted under the concurrent list, which means all...

-The Hindu Justice Prabha Sridevan’s judgment permitting the production and sale of a generic version of a cancer drug is a victory for patients. It posits the public interest, especially in matters of health care, right at the heart of intellectual property rights in India Monday was a remarkable day for cancer patients in India. To them, the country said — “we care.” I am talking about the astounding decision by Justice...

-Live Mint Govt reiterates it will crack down hard on tax evaders, defends steps introduced in Finance Bill to check evasion The government on Tuesday reiterated its intention to crack down hard on tax evaders and defended some of the stringent provisions introduced in the Finance Bill last week to check evasion, including granting wider powers of arrest to taxmen and making certain offences non-bailable. Finance minister P. Chidambaram, in his budget speech...

-The Hindu Bangalore: Many corporates have responded positively to the government’s advice to increase their overall budget by 65 per cent for safety and security, especially of women, revealed a survey undertaken by ASSOCHAM Social Development Foundation (ASDF). According to the findings of the survey on ‘Women Safety and Security Budgets for 2013-14’, some corporates have hiked their budget by 65 per cent while others are in the process of doing it. The...

-The Hindu Bayer's plea dismissed by the Intellectual Property Appellate Board The Intellectual Property Appellate Board (IPAB) on Monday upheld the grant of compulsory licence (CL) to the Hyderabad-based Natco Pharma Limited, a generic drug maker, to produce and market Nexavar, a patented cancer drug of multinational pharma major Bayer Corporation. The order will pave the way for reduction in the prices of costly life saving drugs. Disposing an appeal filed by Bayer...